PRLR and invasive breast carcinoma: RNA expression levels in these BrCa sensitive PDX tumors corresponded to the lower third of all BrCA tumors within the TCGA database suggesting that the majority of BrCa tumors may express sufficient levels of PRLR to render them sensitive to ABBV-176.